1. Abuissa H, Jones PG, Marso SP and O’Keefe JH. Angiotensin-converting enzyme inhibitors or angiotensin receptor blockers for prevention of type 2 diabetes: a meta-analysis of randomized clinical trials. J Am Coll Cardiol
46:821–826, 2005.
2. Ahren B, Landin-Olsson, M, Jansson PA, Svensson, M, Holmes D and Schweizer A. Inhibition of dipeptidyl peptidase-4 reduces glycemia, sustains insulin levels, and reduces glucagon levels in type 2 diabetes. J Clin Endocrinol Metab
89:2078–2084, 2004.
3. Ahren B. Glucagon-like peptide-1 (GLP-1): a gut hormone of potential interest in the treatment of diabetes. Bioessays
20:642–651, 1998.
4. Billaudel B, Faure A, Labriji-Mestaghanmi H and Sutter BC. Direct in vitro effect of 1,25-dihydroxyvitamin D3 on islets insulin secretion in vitamin deficient rats: influence of vitamin D3 pretreatment. Diabetes Metab.
15:85–87, 1989.
5. Bland R, Maskovic D, Hills CE, Hughes SV, Chan SL, Squires PE and Hewison M. Expression of 25-hydroxyvitamin D3-1-a-hydroxylase in pancreatic islets. J. Steroid Biochem Mol Biol
89–90:121–125, 2004.